Calcineurin A gamma and B gene expressions in the whole blood in Japanese patients with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 4, 2008, Pages 1000-1004

  Murata, Masahiko ^a   Tsunoda, Masahiko ^b   Sumiyoshi, Tomiki ^b   Sumiyoshi, Chika ^c   Matsuoka, Tadasu ^a   Suzuki, Michio ^a   Ito, Miho ^a   Kurachi, Masayoshi ^b  

^a National Hospital Organization   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c FUKUSHIMA UNIVERSITY   (Japan)

Author keywords

Calcineurin A gamma; Calcineurin B; Gene expression; Quantitative RT PCR; Schizophrenia; Whole blood

Indexed keywords

BETA ACTIN; CALCINEURIN; CALCINEURIN A GAMMA; CALCINEURIN B; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DOSE RESPONSE; FEMALE; GENE EXPRESSION; HUMAN; JAPANESE; LINEAR REGRESSION ANALYSIS; MALE; MENTAL DISEASE; PSYCHOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHIZOPHRENIA; SCORING SYSTEM;

ACTINS; ADULT; CALCINEURIN; FEMALE; GENE EXPRESSION; HUMANS; JAPAN; MALE; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 42949170440     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.01.013     Document Type: Article

References (39)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 97 (2000) 8104-8109
2. Adlersberg M., Hsiung S.C., Glickstein S.B., Liu K.P., Tamir H., and Schmauss C. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin). J Neurochem 90 (2004) 865-873
3. Aramburu J., Rao A., and Klee C.B. Calcineurin: from structure to function. Curr Top Cell Regul 36 (2000) 237-295
4. Camp N.J., Neuhausen S.L., Tiobech J., Polloi A., Coon H., and Myles-Worsley M. Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method. Am J Hum Genet 69 (2001) 1278-1289
5. Coon H., Myles-Worsley M., Tiobech J., Hoff M., Rosenthal J., Bennett P., et al. Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol Psychiatry 3 (1998) 521-527
6. Eastwood S.L., Burnet P.W., and Harrison P.J. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 57 (2005) 702-710
7. Eastwood S.L., Salih T., and Harrison P.J. Differential expression of calcineurin A subunit mRNA isoforms during rat hippocampal and cerebellar development. Eur J Neurosci 22 (2005) 3017-3024
8. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
9. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A 100 (2003) 8993-8998
10. Greengard P., Allen P.B., and Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23 (1999) 435-447
11. Halim N.D., Weickert C.S., McClintock B.W., Hyde T.M., Weinberger D.R., Kleinman J.E., et al. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 8 (2003) 797-810
12. Kendler K.S., MacLean C.J., O'Neill F.A., Burke J., Murphy B., Duke F., et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 153 (1996) 1534-1540
13. Klee C.B., Crouch T.H., and Krinks M.H. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A 76 (1979) 6270-6273
14. Klee C.B., Ren H., and Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273 (1998) 13367-13370
15. Kontkanen O., Toronen P., Lakso M., Wong G., and Castren E. Antipsychotic drug treatment induces differential gene expression in the rat cortex. J Neurochem 83 (2002) 1043-1053
16. Lieberman D.N., and Mody I. Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Nature 369 (1994) 235-239
17. Ma J., and Liew C.C. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 35 (2003) 993-998
18. Milan D., Griffith J., Su M., Price E.R., and McKeon F. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell 79 (1994) 437-447
19. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 100 (2003) 8987-8992
20. Perrino B.A., Fong Y.L., Brickey D.A., Saitoh Y., Ushio Y., Fukunaga K., et al. Characterization of the phosphatase activity of a baculovirus-expressed calcineurin A isoform. J Biol Chem 267 (1992) 15965-15969
21. Rushlow W.J., Seah Y.H., Belliveau D.J., and Rajakumar N. Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics. J Neurochem 94 (2005) 587-596
22. Rusnak F., and Mertz P. Calcineurin: form and function. Physiol Rev 80 (2000) 1483-1521
23. Seeman P., Weinshenker D., Quirion R., Srivastava L.K., Bhardwaj S.K., Grandy D.K., et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci U S A 102 (2005) 3513-3518
24. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., and Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 10 500-13 (2005) 425
25. Shibasaki F., Hallin U., and Uchino H. Calcineurin as a multifunctional regulator. J Biochem (Tokyo) 131 (2002) 1-15
26. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
27. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 7 (2002) 542-559
28. Takeuchi Y., and Fukunaga K. Different activation of NF-kappaB by stimulation of dopamine D2L and D2S receptors through calcineurin activation. J Neurochem 90 (2004) 155-163
29. Tong G., Shepherd D., and Jahr C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science 267 (1995) 1510-1512
30. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 133 (2005) 1-5
31. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 18 (2002)
32. Vawter M.P., Thatcher L., Usen N., Hyde T.M., Kleinman J.E., and Freed W.J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7 (2002) 571-578
33. Vawter M.P., Ferran E., Galke B., Cooper K., Bunney W.E., and Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res 67 (2004) 41-52
34. Vernon S.D., Unger E.R., Dimulescu I.M., Rajeevan M., and Reeves W.C. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 18 (2002) 193-199
35. Vogel M., Pfeifer S., Schaub R.T., Grabe H.J., Barnow S., Freyberger H.J., et al. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients. Neuropsychobiology 50 (2004) 305-310
36. Wang M.G., Yi H., Guerini D., Klee C.B., and McBride O.W. Calcineurin A alpha (PPP3CA), calcineurin A beta (PPP3CB) and calcineurin B (PPP3R1) are located on human chromosomes 4, 10q21®q22 and 2p16®p15 respectively. Cytogenet Cell Genet 72 (1996) 236-241
37. Whistler T., Unger E.R., Nisenbaum R., and Vernon S.D. Integration of gene expression, clinical, and epidemiologic data to characterize chronic fatigue syndrome. J Transl Med 1 (2003) 10
38. Yamada K., Gerber D.J., Iwayama Y., Ohnishi T., Ohba H., Toyota T., et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A 104 (2007) 2815-2820
39. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., et al. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107 (2001) 617-629